The AI-driven personalized nutrition has been further bolstered by the rising adoption of medical wearable devices, and smartphones that help to collect vital information for disease monitoring and management. Moreover, AI integration with nutrigenomics can help in determining vast amount of data generated through genomics, and metabolomics. Notably, this field is at the forefront of innovation, catering the attention of industrial players.For instance, in February 2025, Fay (US), a digital nutr...

Several market players are leveraging partnerships and collaborations to develop cost-effective and cutting-edge solutions for microbiome diagnostics. For instance, in February 2025, Leucine Ruch Bio (India) announced a strategic partnership with Precision Diagnosticos (Brazil) to expand BugSpeaks (Leucine Rich Bio’s flagship microbiome testing technology) to Brazilian market. Besides technology expansion, the industrial players also focus on initiating education programs to raise awareness ab...

The growing skin care issues, such as allergies due to prolonged use of synthetic chemical based products or relying on non-invasive aesthetic treatment have led to a significant shift towards natural and organic skin care products. Moreover, consumers are more focused on sustainability, eco-friendly and prioritizing health, which further supports the growth of organic skin care product market.With increasing preferences of natural and organic skincare products, global leaders, such as Weleda, L...

The global medical device CRO market, valued at USD 20.4 billion in 2025, is projected to grow to USD 22.0 billion in 2026 and USD 43.6 billion by 2035, representing a CAGR of 7.9% during the forecast period 2026 to 2035. The demand for advanced medical devices has intensified the pressure on medical device companies to not only meet rigorous regulatory standards but also expand their product offerings.

The global KRAS market size, valued at USD 476 million in 2024, is projected to reach USD 557 million in 2025 and USD 3,894 million by 2035, representing a CAGR of 21% during the forecast period. One of these oncogenic mutations is KRAS, which was identified to be associated with nearly 30% of cancer in humans. One of the key objectives of KRAS market report was to estimate the current market size, opportunity and the market growth potential, over the forecast period, till 2035. We have provided...

The global organic skin care market size is valued at USD 13.30 billion in 2025 and is poised to reach USD 30.08 billion by 2035. Driven by the growing demand for natural skin care products, several industrial players are undertaking active initiatives to strengthen their product portfolio. Recently, Aroma Magic (India) launched a new “Blossom Kochhar Aroma Magic Skin Firming Comb,” which is prepared with blossom kochhar aroma magic beautiful skin oil, blossom kochhar aroma magic firming gel...

The global green ammonia market, valued at USD 2,672 million in 2025, is projected to reach USD 8,002 million in 2026 and USD 55,056 million by 2032, with a 37.91% CAGR during the forecast period 2026 to 2032. In April 2024, ReNew E-Fuels entered into an agreement with JERA to develop a green ammonia production plant in India. In June 2024, Hygenco Green Energies entered into an agreement with Ameropa to boost the former’s green ammonia export, facilitating the worldwide shift towards renew...

The global antiviral drugs market size is estimated to grow from USD 69 billion in 2025 to reach USD 74 billion in 2026 and USD 127 billion by 2035, representing a higher CAGR of 6.1% during the forecast period 2026 to 2035. According to the National Institute for Health’s reports, around 52 million (33%) deaths are caused by infectious diseases annually. COVID-19 is one of the latest examples of an infectious disease that caused 3 million deaths worldwide. Before COVID-19, Human Immunodeficie...

The spatial genomics and transcriptomics market, valued at USD 6.5 billion in 2025, is projected to reach USD 7.3 billion in 2026 and USD 20.1 billion by 2035, with a 11.9% CAGR during the forecast period 2026 to 2035. Researchers have focused their efforts from decoding the primary sequence of genes to analyzing the location and interaction of cell types, and biomarkers (primarily, DNA, RNA and proteins), through a process known as spatial phenotyping. These spatial phenotyping platforms can be...

The DNA data storage market size is estimated to be worth USD 34.8 million in 2024 and is expected to reach USD 532 million by 2035 growing at a CAGR of 28% during the forecast period, till 2035. The ongoing technological advancements, rising popularity of social media, use of virtual platforms during the COVID-19 pandemic and digitalization of the various aspects in the modern world have led to the generation of colossal amount of digital data. The reliable and secure storage and accessibility...

The global 3D cell culture market, valued at USD 2.16 billion in 2025, is projected to reach USD 2.61 billion in 2026 and USD 8.90 billion by 2035, with a 14.6% CAGR during the forecast period 2026 to 2035. Driven by the increasing requirement of animal model alternatives, the 3D cell culture market is anticipated to grow at a higher rate during the forecast period. According to our projection, use of 3d cell culture systems for cancer research is dominating the market and is likely to hold 41%...

The global clinical trial patient recruitment services market, valued at USD 11.8 billion in 2025, is projected to reach USD 12.8 billion in 2026 and USD 26.2 billion by 2035, with a 8.3% CAGR during the forecast period 2026 to 2035. Studies suggest that around 40% of the total investment made for the development of a drug candidate is dedicated to clinical trials. However, around 80% of the clinical trials are delayed due to insufficient patient recruitment. Further, retaining patients is also...

The mitochondrial disease therapies market, valued at USD 518 million in 2025 to reach USD 660 million in 2026 and USD 1,817 million by 2030, with a higher CAGR of 28.8% during the forecast period, 2026 to 2030. Mitochondrial diseases are characterized by chronic, genetic and progressive medical symptoms that arise due to inherited or spontaneous mutations in mitochondrial DNA (a small, circular, double-stranded with ~16,500 base pairs that exists outside of the nucleus). It is worth highlighti...

The global cancer diagnostics market is currently worth around USD 156 billion and is expected to reach USD 319 billion by 2032. It is expected to grow at a CAGR of 9.3% till 2032. According to the American Cancer Society, by 2050, the number of cancer cases will be predicted to increase to 35 million based solely on projected population growth. Further, Studies have indicated that misdiagnosis or late diagnosis can severely impact survival rates, underscoring the critical need for reliable diag...

The cytotoxic drugs and HPAPI manufacturing market, valued at USD 13.98 billion in 2025, is projected to grow to USD 15.59 billion in 2026 and USD 46.41 billion by 2035, representing a CAGR of 12.89% during the forecast period 2026 to 2035. Around 40% of approved drugs in the market are classified as highly potent. Of these, 60% of the approved HPAPI-based drugs are used for cancer treatment, owing to their ability to exhibit highly effective therapeutic responses with minimal dosage.

The global T-cell therapy market, valued at USD 6.5 billion in 2025, is projected to grow to USD 8.1 billion in 2026 and USD 20.9 billion by 2035, representing a CAGR of 11.2% during the forecast period 2026 to 2035. According to NIH, in 2024, around 2 million people are estimated to be diagnosed with various types of cancer in the U.S. alone. The US FDA approved multiple T cell therapies targeting cancer (in reverse chronological order), such as Obecabtagene autoleucel / Aucatzyl (relapsed or r...

Owing to the increased adoption rate of digital solutions and rise in the demand for remote healthcare services, the companies involved in the women

The NFT in Healthcare market, valued at USD 208 million in 2025, is projected to reach USD 240 million in 2026 and USD 1,117 million by 2035, with a 18.6% CAGR during the forecast period 2026 to 2035. The new research study consists of market trends, porter’s five forces, detailed market analysis, and market sizing and opportunity analysis.

The global healthcare cold chain logistics market is estimated to grow from USD 197.7 billion in 2024 to reach USD 207.0 billion in 2025 and USD 320.9 billion by 2035, representing a higher CAGR of 4.5% during the forecast period. Given the recent technical breakthroughs and advances, and the steadily rising demand for biopharmaceuticals, the reliance on cold chain is expected to increase substantially, causing logistics service providers to contemplate, devise and implement flexible business st...

The global site management organization market, valued at USD 12.4 billion in 2025, is projected to reach USD 13.6 billion in 2026 and USD 31.6 billion by 2035, with a 9.8% CAGR during the forecast period 2026 to 2035. Studies suggest that around 40% of the total investment made for the development of drug candidate is dedicated to clinical trials; this is equivalent to an expenditure of USD 78 billion annually. Currently, around 250 companies claim to be actively providing SMO services to drug...